http://www.BreastCancer.net
提供最新乳癌研究的新聞及相關文章。
http://www.breast-cancer-research.com
搜尋有關乳癌研究及醫療突破的文章。
http://www.sisterstudy.org
美國一個關於乳癌的長期研究，研究對象為擁有乳癌病患姊妹的35至74歲女性。
http://www.thebreastsite.com
網站為女性提供最新健康資訊及提倡關注乳房健康等。
The National Lymphedema Network (NLN) is an internationally recognized non-profit organization founded in 1988 by Saskia R.J. Thiadens, R.N. to provide education and guidance to lymphedema patients, health care professionals and the general public by disseminating information on the risk reduction and management of primary and secondary lymphedema.
The NLN is supported by tax-deductible donations and is a driving force behind the movement in the U.S. to standardize quality treatment for lymphedema patients nationwide. In addition, the NLN supports research into the causes and possible alternative treatments for this often incapacitating, long-neglected condition.
處理淋巴水腫的資訊
National Lymphedema Network (NLN)的網站，教育病人、醫護人員及大眾有關淋巴水腫的資訊，同時指導他們如何料理原發及繼發性的淋巴水腫。
A chest X-ray showing cancer in the right lung
Hundreds of thousands of people are diagnosed with cancer every year in the UK. It is not one disease; there are over 200 different types, each with its own symptoms, methods of diagnosis and treatment.
One in three people will be affected by cancer at some stage in their life. We have more information on the most common types affecting people in the UK along with the general treatment, diagnosis process and care you’ll receive if you’re diagnosed.
英國廣播公司BBC的癌症資訊專頁超深入淺出!
http://www.bbc.co.uk/health/phys … ns/in_depth/cancer/
NCCN welcomes the opportunity to work with reporters on all cancer-related topics. NCCN offers members of the media access to scientific and medical experts, news releases, background research, and much more. We can also help connect press with investigators and clinicians who can discuss research, treatment and issues related to cancer through coordination with media contacts at NCCN Member Institutions.
The Lancet publishes a weekly journal and three monthly specialty journals in the fields of oncology, neurology, and infectious diseases. All Lancet specialty journals have existed as both print and online medical journals since first published. The history of each journal and information for authors can be found at the following links:
About The Lancet
About The Lancet Infectious Diseases
About The Lancet Neurology
About The Lancet Oncology
About AfrOx
AfrOx's mission is to partner with African countries and assist them with implementing comprehensive cancer prevention and control programmes.
Cancer in Africa
Cancer is a global problem accounting for almost 13% of all deaths worldwide. This equates to over 7 million people a year, more than is caused by HIV/AIDS, TB and malaria combined.
Although the world is rightly focused on controlling the spread of these infectious diseases, we are ignoring the growing burden of CANCER in developing countries.
By 2020 there are expected to be 16 million new cases of cancer every year, 70% of which will be in developing countries where governments are least prepared to address the growing cancer burden and where survival rates are often less than half those of more developed countries. The time to take action is now.
African countries are the least able of all developing countries to cope, having few cancer care services. Lack of resources and basic infrastructure mean that most Africans have no access to cancer screening, early diagnosis, treatment or palliative care. Consequently a diagnosis of cancer leads, in most cases, to a painful and distressing death.
In addition, in many African countries the combined effects of cancer, poverty, deprivation and infectious diseases hinder the development of a sustainable population and consequently a sustainable future.
The Way Forward
AfrOx believes that the only way to effectively prevent, detect and treat the rising number of cancers in Africa is to develop an international alliance – including governments, international organizations, NGOs, research institutions and the pharmaceutical industry.
Strong local and international leadership is essential. We believe that African governments must be the driving force to develop and implement cancer control in their countries, with technical, policy and financial support provided by at every level by the international alliance.
A comprehensive cancer control strategy must bring together prevention, early detection and diagnosis, treatment, palliative care and the investment needed to deliver these services in terms of trained staff, equipment, relevant drugs and information systems, as well as public education.
Only in this way can achievable and sustainable national cancer plans that are evidence based, priority driven and resource appropriate for African countries be developed, and AfrOx are committed to doing this.
There are grounds for optimism. With concerted early action cancer in Africa is a disease that can be tackled.
We hope that you will work together with us to achieve this goal.
ESMO, the European Society for Medical Oncology
The European Society for Medical Oncology (ESMO) is the leading European professional organization, committed to advancing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care.
Since its founding in 1975 as a non-profit organization, ESMO’s mission has been to advance cancer care and cure. We achieve this through fostering and disseminating good science that leads to better medicine and determines best practice. In this way ESMO fulfils its goal to support oncology professionals in providing people with cancer with the most effective treatments available and the high-quality care they deserve.
About UICC
Founded in 1933, the Union for International Cancer Control (UICC) is the largest cancer fighting organisation of its kind, with more than 400 member organisations across 120 countries.
With its headquarters in Geneva, Switzerland, it is the leading non-governmental, non-profit, non-political and non-sectorian cancer organisation. UICC’s mission is to eliminate cancer as a life-threatening disease for future generations.
UICC is committed to delivering the targets of the World Cancer Declaration through strategic partnerships involving members and other institutions interested in fighting cancer. Together we aim to save millions of lives by focusing on what needs to be done by taking the lead in:
Raising awareness and education
Global network of influence
Taking action where it matters.
http://www.uicc.org/
We are the world’s leading charity dedicated to beating cancer through research.
We’ve saved millions of lives with our groundbreaking work into preventing, diagnosing and treating cancer. People’s chances of surviving cancer have doubled in the last 40 years, and we’ve been at the heart of that progress.
But more than one in three of us will still get cancer at some point. Our vital work, funded entirely by the public, will help ensure that millions more people survive.
http://aboutus.cancerresearchuk.org/
Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia works to reduce the impact of cancer and improve the well-being of those diagnosed by ensuring that evidence informs cancer prevention, screening, diagnosis, treatment and supportive care.
Cancer Australia works collaboratively and liaises with a wide range of groups, including those affected by cancer, key stakeholders and service providers with an interest in cancer control. The agency also focuses on populations who experience poorer health outcomes, including Aboriginal and Torres Strait Islander peoples and people living in rural and remote Australia.
As the lead national cancer control agency, Cancer Australia also makes recommendations to the Australian Government about cancer policy and priorities.
